Q2 2022

Filed Nov 10, 2021 · 10-Q · 10 days after period end · 0001683168-21-005411

Q2 2022 · 10-Q

Revenue

$45.00K

— vs Q2 2021

Net Income

$15.01K

N/M vs Q2 2021

EPS Diluted

$0.00

— vs Q2 2021

Operating Income-$29,991N/M

Operating Cash Flow

Same quarter

Metric	Q2 2022	Q2 2021	Q2 2020	Q2 2019
Revenue	$45.00K	$0.00	$0.00	—
Net Income	$15.01K	-$12.39K	-$19.52K	-$40.05K
EPS Diluted	$0.00	$0.00	$0.00	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

VitaNova Life Sciences Corp · CIK 1699709 · Engraved from SEC EDGAR